Although several glycomic changes did not reach statistical significance after correction for multiple testing, the overall biological signal consistently favored reduced oxidative and inflammatory activation in the empagliflozin group.
← all excerpts
Acute vascular redox modulation by SGLT2 inhibition in non-diabetic patients.
1
—
—